Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-19

FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved the original application for a fixed-dose combination of olanzapine and fluoxetine (olanzapine/fluoxetine) by Teva Pharmaceuticals USA, Inc., for b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine and fluoxetine (olanzapine; fluoxetine)

Snippet

ORIG AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)